Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry

Journal of Cardiovascular Electrophysiology

Volumn 27, Issue 5, 2016, Pages 555-562

  Choudhary, Naila ^a   Tompkins, Christine ^b   Polonsky, Bronislava ^c   McNitt, Scott ^c   Calkins, Hugh ^d   Mark Estes, N A ^e   Krahn, Andrew D ^f   Link, Mark S ^e   Marcus, Frank I ^g   Towbin, Jeffrey A ^h   Zareba, Wojciech ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

arrhythmogenic right ventricular cardiomyopathy, gender differences; clinical outcomes

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; FOLLOW UP; GENETIC SCREENING; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NORTH AMERICAN; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; T WAVE; T WAVE INVERSION; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; BIOPSY; CLINICAL TRIAL; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION; GENETICS; HEALTH DISPARITY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MUTATION; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTOR; VENTRICULAR FIBRILLATION;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; BIOPSY; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NORTH AMERICA; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEX FACTORS; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 84962518826     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12947     Document Type: Article

References (22)

1. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y,: Right ventricular dysplasia: A report of 24 adult cases. Circulation 1982; 65: 384-398.
2. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W,: Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541.
3. Basso C, Corrado D, Marcus FI, Nava A, Thiene G,: Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373: 1289-1300.
4. Noorman M, van der Heyden MA, van Veen TA, Cox MG, Hauer RN, de Bakker JM, van Rijen HV,: Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. J Mol Cell Cardiol 2009; 47: 23-31.
5. Cox MG, van der Zwaag PA, van der Werf C, van der Smagt JJ, Noorman M, Bhuiyan ZA, Wiesfeld AC, Volders PG, van Langen IM, Atsma DE, Dooijes D, van den Wijngaard A, Houweling AC, Jongbloed JD, Jordaens L, Cramer MJ, Doevendans PA, de Bakker JM, Wilde AA, van Tintelen JP, Hauer RN,: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation 2011; 123: 2690-2700.
6. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F,: Spectrum of clinicopathological manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J Am Coll Cardiol 1997; 30: 1512-1520.
7. Bauce B, Frigo G, Marcus FI, Basso C, Rampazzo A, Maddalena F, Corrado D, Winnicki M, Daliento L, Rigato I, Steriotis A, Mazzotti E, Thiene G, Nava A,: Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol 2008; 102: 1252-1257.
8. Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, Murray B, te Riele AS, van den Berg MP, Bikker H, Atsma DE, de Groot NM, Houweling AC, van der Heijden JF, Russell SD, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Calkins H, Hauer RN,: Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Eur Heart J 2015; 36: 847-855.
9. Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld AC, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Jan Cramer M, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H,: Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet 2015; 8: 437-446.
10. Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, Gear K,; ARVD/C Investigators: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): A multidisciplinary study: Design and protocol. Circulation 2003; 107: 2975-2978.
11. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, Simson MB, DiCarlo L, Echt DS, Packer D, Greer GS, Talajic M,; the MUSTT Investigators: Prevention of sudden death in patients with coronary artery disease: The Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis 1993; 36: 215-226.
12. Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A,: Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005; 26: 1666-1675.
13. Syrris P, Ward D, Asimaki A, Sen-Chowdhry S, Ebrahim HY, Evans A, Hitomi N, Norman M, Pantazis A, Shaw AL, Elliott PM, McKenna WJ,: Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 2006; 113: 356-364.
14. Simonson E, Blackburn H, Puchner TC, Eisenberg P, Ribeiro F, Meja M,: Sex differences in the electrocardiogram. Circulation 1960; 22: 598-601.
15. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A,: Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690-695.
16. Marcus FI, Zareba W, Sherrill D,: Evaluation of the normal values for signal averaged electrocardiogram. J Cardiovasc Electrophysiol 2007; 18: 231-233.
17. Yakubo S, Ozawa Y, Saito S, Kasamaki Y, Komaki K, Hanakawa K, Sasaki Y, Aruga M, Miyazawa I, Kanda T, Sekiguchi K, Shimabukuro H, Nakamura T, Okumura N,: Normal limits of high-resolution signal-averaged ECG parameters of Japanese adult men and women. J Electrocardiol 2000; 33: 225-231.
18. Kamath GS, Zareba W, Delaney J, Koneru JN, McKenna W, Gear K, Polonsky S, Sherrill D, Bluemke D, Marcus F, Steinberg JS,: Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2011; 8: 256-262.
19. Santangeli P, Pieroni M, Dello Russo A, Casella M, Pelargonio G, Di Biase L, Macchione A, Burkhardt JD, Bellocci F, Santarelli P, Tondo C, Natale A,: Correlation between signal-averaged ECG and the histologic evaluation of the myocardial substrate in right ventricular outflow tract arrhythmias. Circ Arrhythm Electrophysiol 2012; 5: 475-483.
20. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ,: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insight into patterns of disease expression. Circulation 2007; 115: 1710-1720.
21. Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI,: Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010; 122: 1144-1152.
22. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D,: Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004; 109: 1503-1508.